Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The effect of aldosterone on glucose metabolism

  • 268 Accesses

  • 55 Citations

Abstract

There is an association of glucose intolerance and diabetes with primary aldosteronism, but the frequency and mechanisms are not clear. This paper reviews the possible mechanisms of impaired glucose metabolism in primary aldosteronism. Patients with primary aldosteronism can have impaired pancreatic insulin release and reduction in insulin sensitivity. These effects may be due to hypokalemia, but the evidence suggests other factors such as a direct impact of excess aldosterone on insulin action in contributing to the metabolic dysfunction. In general adrenal surgery in cases of aldosterone-producing adenoma will correct the metabolic abnormalities, but it is less sure if treatment with spironolactone in cases of idiopathic hyperplasia will correct impaired glucose tolerance.

This is a preview of subscription content, log in to check access.

References and Recommended Reading

  1. 1.

    Conn JW, Knopf RF, Nesbit RM: Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg 1964, 107:159–172. Classic paper on this subject.

  2. 2.

    Conn JW: Hypertension, the potassium ion and impaired carbohydrate tolerance. N Engl J Med 1965, 273:1135–1143.

  3. 3.

    Stern N, Tuck M: The adrenal cortex and mineralocorticoid hypertension. In Manual of Endocrinology and Metabolism. Edited by Lavin N. Philadelphia: Lippincott Williams & Wilkins; 2002:115–138.

  4. 4.

    Blumfeld JD, Sealy JE, Schlussel F, et al.: Diagnosis and treatment of primary aldosteronism. Ann Intern Med 1994, 121:877–885.

  5. 5.

    Ganguly A: Primary aldosteronism. N Engl J Med 1998, 339:1828–1834.

  6. 6.

    Irrony I: Correctable subsets of primary aldosteronism. Am J Hypertens 1990, 3:576–582.

  7. 7.

    Shimamoto K, Shiiki M, Ise T, et al.: Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism? J Hum Hypertens 1994, 10:755–759.

  8. 8.

    Shamiss A, Carroll J, Rosenthal T: Insulin resistance in secondary hypertension. Am J Hypertens 1992, 5:26–28.

  9. 9.

    Škrha J, Šindelka G, Prázný M, et al.: Insulin action in primary aldosteronism [abstract]. Diabetologia 1997, 40(Suppl A):291.

  10. 10.

    Šindelka G, Widimský J, Haas T, et al.: Insulin action in primary aldosteronism before and after surgical or pharmacological treatment. Exp Clin Endocrinol Diabetes 2000, 108:21–25. This group has done the most careful clinical studies to characterize the mechanisms of metabolic dysfunction in primary aldosteronism.

  11. 11.

    Widimský J, Strauch B, Šindelka G, Škrha J: Can primary hyperaldosteronism be considered a specific form of diabetes mellitus? Physiol Res 2001, 50:603–607.

  12. 12.

    The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000, 23(Suppl 1):S4-S19.

  13. 13.

    Ishimori M, Takeda N, Okumura S, et al.: Increased insulin sensitivity in patients with aldosterone producing adenoma. Clin Endocrinol 1994, 41:433–438.

  14. 14.

    Rowe JW, Tobin JD, Rosa RM, Andres R: Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism 1980, 29:498–502.

  15. 15.

    Saglid U, Anderson V, Andreasen PB: Glucose tolerance and insulin responsiveness in experimental potassium depletion. Acta Med Scand 1961, 169:243–251.

  16. 16.

    Nestler JE, McClanahan MA: Diabetes and adrenal disease. Baillieres Clin Endocrinol Metab 1992, 4:829–847.

  17. 17.

    Mani H, Takeda K, Kiyama M, et al.: A case of nephrotic syndrome with diabetes mellitus and primary aldosteronism. Nippon Jinzo Gakkai Shi 1999, 41:442–447.

  18. 18.

    Ranade K, Wu KD, Risch N, et al.: Genetic variation in aldosterone synthase predicts plasma glucose levels. Proc Natl Acad Sci U S A 2001, 98:13219–13224.

  19. 19.

    Petrasek D, Jensen G, Tuck M, Stern N: In vitro effect of insulin on aldosterone production in rat zona glomerulosa cells. Life Sci 1992, 50:1781–1787.

  20. 20.

    Laverty G, Bjarnadottir S, Elrond VS, et al.: Aldosterone suppresses expression of an avian colonic sodium-glucose transporter. Am J Physiol Regul Integr Comp Physiol 2001, 281:R1041-R1050.

  21. 21.

    Campion J, Maestro B, Mata F, et al.: Inhibition by aldosterone of insulin receptor mRNA levels and insulin binding in U-937 human promonocytic cells. J Steroid Biochem Mol Biol 1999, 70:211–218.

  22. 22.

    Campion J, Maestro B, Molero N, et al.: Aldosterone impairs insulin responsiveness in U-937 human promonocytic cells via the downregulation of its own receptor. Cell Biochem Funct 2002, 20:237–245. These investigators present exciting data to show direct effects of aldosterone on the insulin receptor and insulin action.

  23. 23.

    Carranza MC, Torres A, Calle C, et al.: Diminucion en numero y en la afinidad de los insulina en el tejido adipso subcutaneo de un paciente con hyperaldosteronismo primero. Rev Clin Exp 1991, 188:414–417.

  24. 24.

    Campion J, Lahera V, Cachofiero V, et al.: In vivo tissue specific modulation of rat insulin receptor gene expression in an experimental model of mineralocorticoid excess. Mol Cell Biochem 1998, 185:177–182.

  25. 25.

    Sauer J, Castren M, Hopfner U, et al.: Inhibition of lipopolysaccharide-induced monocyte interleuken-1 receptor antagonist synthesis by cortisol: involvement of the mineralocorticoid system. J Clin Endocrinol Metab 1996, 81:73–79.

  26. 26.

    Wantanabe Y, Akabayashi A, McWen BS: Adrenal steroid regulation of neuropeptide Y (NPY) mRNA differences between dentate and locus coruleus and arcuate nuclease. Mol Brain Res 1995, 28:135–140.

  27. 27.

    Ahamad M, Medford RM: Evidence for the regulation of Na+K+-ATPase a1 gene expression through the interaction of aldosterone and CAMP-inducible transcriptional factors. Steroids 1995, 60:147–152.

  28. 28.

    Silvestre JS: Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 1999, 99:2694–2699.

  29. 29.

    Torpy DJ: Leptin levels are suppressed in primary aldosteronism. Horm Metab Res 1999, 31:533–536.

  30. 30.

    Haluzik M, Šindelka G, Widimský J, et al.: Serum leptin levels in patients with primary hyperaldosteronism before and after treatment: relationships to insulin sensitivity. J Hum Hypertens 2002, 16:41–45.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Corry, D.B., Tuck, M.L. The effect of aldosterone on glucose metabolism. Current Science Inc 5, 106–109 (2003). https://doi.org/10.1007/s11906-003-0065-2

Download citation

Keywords

  • Insulin Sensitivity
  • Insulin Receptor
  • Oral Glucose Tolerance Testing
  • Insulin Action
  • Hyperinsulinemic Euglycemic Clamp